BioCentury
ARTICLE | Financial News

Gossamer Bio prices $276M IPO

February 13, 2019 11:19 PM UTC

Gossamer Bio Inc. (NASDAQ:GOSS) raised $276 million in an upsized IPO priced late Feb. 7 . Gossamer was up $1.94 (12%) to $17.94 on its first day of trading Feb. 8.

Launched officially just 13 months ago by ex-Receptos Inc. executives, Gossamer is developing therapeutics for inflammation, immune disorders and oncology. In the IPO, the company sold 17.3 million shares at $16, giving it a valuation just above $1 billion...

BCIQ Company Profiles

Gossamer Bio Inc.